HUP0202712A2 - D4-antagonistákként alkalmazható tienoizoxazol fenoxi helyettesítetlen etil- és propilszármazékok, intermedierjeik és eljárás az előállításukra, és a vegyületeket tartalmazó gyógyszerkészítmények - Google Patents
D4-antagonistákként alkalmazható tienoizoxazol fenoxi helyettesítetlen etil- és propilszármazékok, intermedierjeik és eljárás az előállításukra, és a vegyületeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0202712A2 HUP0202712A2 HU0202712A HUP0202712A HUP0202712A2 HU P0202712 A2 HUP0202712 A2 HU P0202712A2 HU 0202712 A HU0202712 A HU 0202712A HU P0202712 A HUP0202712 A HU P0202712A HU P0202712 A2 HUP0202712 A2 HU P0202712A2
- Authority
- HU
- Hungary
- Prior art keywords
- compounds
- group
- antagonists
- intermediates
- disorder
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 7
- 239000005557 antagonist Substances 0.000 title abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 title abstract 2
- 239000000543 intermediate Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000011117 substance-related disease Diseases 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- -1 1-(phenylmethyl)-pyrrolidin-3-yl group Chemical group 0.000 abstract 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 abstract 1
- 208000027448 Attention Deficit and Disruptive Behavior disease Diseases 0.000 abstract 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 abstract 1
- 208000027691 Conduct disease Diseases 0.000 abstract 1
- 206010013654 Drug abuse Diseases 0.000 abstract 1
- 201000004311 Gilles de la Tourette syndrome Diseases 0.000 abstract 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000027089 Parkinsonian disease Diseases 0.000 abstract 1
- 206010034010 Parkinsonism Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 206010043118 Tardive Dyskinesia Diseases 0.000 abstract 1
- 208000000323 Tourette Syndrome Diseases 0.000 abstract 1
- 208000016620 Tourette disease Diseases 0.000 abstract 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 206010013663 drug dependence Diseases 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 208000024196 oppositional defiant disease Diseases 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
A találmány tárgyát képezik a (I) általános képletű vegyületek, azokgyógyászatilag elfogadható sói és sztereoizomerjei - a képletben Ajelentése 2-3 szénatomos alkilén-N(R1) (R2) vagy 1- (fenilmetil)-pirrolidin-3-il-csoport; R1 jelentése - többek között - (CH2)nQ-csoport, ahol Q jelentése - többek között - tienil-csoport R2jelentése H-atom vagy 1-6 szénatomos alkilcsoport; és m értéke 0 vagy1. A vegyületek D4-antagonistákként alkalmazható tieno-izoxazol-fenoxihelyettesítetlen etil- és propil-származékok körébe tartoznak. Azemlített vegyületek alkalmazhatók a D4-receptor gátlása általszabályozható orvosi állapotok kezelésében. Ezen állapotok körébetartoznak például a figyelemhiányos hiperaktivitási rendellenesség, arögeszmés-kényszeres rendellenesség, pszichózisok, droggal valóvissszaélés, drogfüggőség, Parkinson-kór, parkinsonizmus, retardáltdyskenisa, Gilles de la Tourette szindróma, magatartászavar ésellenszegülő-kihívó rendellenesség. A találmány tárgyát képzik továbbáa találmány szerinti vegyületeket tartalmazó gyógyászati készítmények,a vegyületek intermedierjei és a vegyületek említett csoportjánakelőállítására irányuló eljárások. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39615699A | 1999-09-14 | 1999-09-14 | |
| PCT/US2000/024949 WO2001019832A2 (en) | 1999-09-14 | 2000-09-13 | Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0202712A2 true HUP0202712A2 (hu) | 2002-12-28 |
| HUP0202712A3 HUP0202712A3 (en) | 2004-12-28 |
Family
ID=23566087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0202712A HUP0202712A3 (en) | 1999-09-14 | 2000-09-13 | Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists, their intermediates, process for their preparation and pharmaceutical compositions containing the compounds |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1216249B1 (hu) |
| JP (1) | JP4717306B2 (hu) |
| KR (1) | KR20020027644A (hu) |
| AR (1) | AR032135A1 (hu) |
| AT (1) | ATE254620T1 (hu) |
| AU (1) | AU7577200A (hu) |
| BR (1) | BR0014513A (hu) |
| CA (1) | CA2383327C (hu) |
| CZ (1) | CZ2002896A3 (hu) |
| DE (1) | DE60006698T2 (hu) |
| DK (1) | DK1216249T3 (hu) |
| EA (1) | EA004177B1 (hu) |
| EE (1) | EE200200133A (hu) |
| ES (1) | ES2206305T3 (hu) |
| HU (1) | HUP0202712A3 (hu) |
| IL (1) | IL148522A0 (hu) |
| MX (1) | MXPA02002690A (hu) |
| NO (1) | NO20021249L (hu) |
| PL (1) | PL354481A1 (hu) |
| PT (1) | PT1216249E (hu) |
| SK (1) | SK3502002A3 (hu) |
| WO (1) | WO2001019832A2 (hu) |
| ZA (1) | ZA200201760B (hu) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0207449D0 (en) * | 2002-03-28 | 2002-05-08 | Glaxo Group Ltd | Novel compounds |
| WO2018166855A1 (en) | 2017-03-16 | 2018-09-20 | Basf Se | Heterobicyclic substituted dihydroisoxazoles |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4728651A (en) * | 1985-10-24 | 1988-03-01 | Hoechst-Roussel Pharmaceuticals Inc. | Antihypertensive thieno-isoxazoles and -pyrazoles |
| US6187774B1 (en) * | 1996-03-04 | 2001-02-13 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused heterocyclic compounds and pharmaceutical applications thereof |
| HUP9603001A3 (en) * | 1996-10-30 | 1999-07-28 | Richter Gedeon Vegyeszet | Heterocycle compounds comprising nitrogen, process for producing them and pharmaceutical compositions containing the same |
| WO1999040067A2 (en) * | 1998-02-09 | 1999-08-12 | Duphar International Research B.V. | Benzisoxazole derivatives having d4-antagonistic activity |
-
2000
- 2000-09-13 DK DK00964967T patent/DK1216249T3/da active
- 2000-09-13 ES ES00964967T patent/ES2206305T3/es not_active Expired - Lifetime
- 2000-09-13 JP JP2001523409A patent/JP4717306B2/ja not_active Expired - Fee Related
- 2000-09-13 MX MXPA02002690A patent/MXPA02002690A/es active IP Right Grant
- 2000-09-13 EP EP00964967A patent/EP1216249B1/en not_active Expired - Lifetime
- 2000-09-13 AT AT00964967T patent/ATE254620T1/de not_active IP Right Cessation
- 2000-09-13 IL IL14852200A patent/IL148522A0/xx unknown
- 2000-09-13 DE DE60006698T patent/DE60006698T2/de not_active Expired - Lifetime
- 2000-09-13 AU AU75772/00A patent/AU7577200A/en not_active Abandoned
- 2000-09-13 WO PCT/US2000/024949 patent/WO2001019832A2/en not_active Ceased
- 2000-09-13 KR KR1020027003354A patent/KR20020027644A/ko not_active Withdrawn
- 2000-09-13 PL PL00354481A patent/PL354481A1/xx unknown
- 2000-09-13 PT PT00964967T patent/PT1216249E/pt unknown
- 2000-09-13 SK SK350-2002A patent/SK3502002A3/sk unknown
- 2000-09-13 BR BR0014513-0A patent/BR0014513A/pt not_active IP Right Cessation
- 2000-09-13 CA CA002383327A patent/CA2383327C/en not_active Expired - Fee Related
- 2000-09-13 CZ CZ2002896A patent/CZ2002896A3/cs unknown
- 2000-09-13 EA EA200200357A patent/EA004177B1/ru not_active IP Right Cessation
- 2000-09-13 HU HU0202712A patent/HUP0202712A3/hu unknown
- 2000-09-13 EE EEP200200133A patent/EE200200133A/xx unknown
- 2000-09-13 AR ARP000104794A patent/AR032135A1/es not_active Application Discontinuation
-
2002
- 2002-03-01 ZA ZA200201760A patent/ZA200201760B/en unknown
- 2002-03-13 NO NO20021249A patent/NO20021249L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003509431A (ja) | 2003-03-11 |
| WO2001019832A3 (en) | 2001-10-04 |
| MXPA02002690A (es) | 2004-09-10 |
| AR032135A1 (es) | 2003-10-29 |
| ES2206305T3 (es) | 2004-05-16 |
| NO20021249D0 (no) | 2002-03-13 |
| DE60006698D1 (de) | 2003-12-24 |
| KR20020027644A (ko) | 2002-04-13 |
| NO20021249L (no) | 2002-05-10 |
| CA2383327C (en) | 2009-11-03 |
| EP1216249A2 (en) | 2002-06-26 |
| WO2001019832A2 (en) | 2001-03-22 |
| DK1216249T3 (da) | 2004-03-15 |
| HUP0202712A3 (en) | 2004-12-28 |
| ATE254620T1 (de) | 2003-12-15 |
| ZA200201760B (en) | 2003-08-27 |
| PL354481A1 (en) | 2004-01-26 |
| IL148522A0 (en) | 2002-09-12 |
| SK3502002A3 (en) | 2002-09-10 |
| BR0014513A (pt) | 2002-07-02 |
| EA004177B1 (ru) | 2004-02-26 |
| JP4717306B2 (ja) | 2011-07-06 |
| DE60006698T2 (de) | 2004-09-23 |
| PT1216249E (pt) | 2004-04-30 |
| EP1216249B1 (en) | 2003-11-19 |
| AU7577200A (en) | 2001-04-17 |
| EA200200357A1 (ru) | 2002-10-31 |
| CZ2002896A3 (cs) | 2002-08-14 |
| EE200200133A (et) | 2003-04-15 |
| CA2383327A1 (en) | 2001-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0203425A2 (en) | Quinazoline derivatives, process for their preparation and their use | |
| EP1619192A3 (en) | Aryl fused azapolycyclic compounds | |
| DE50307267D1 (de) | Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel | |
| MXPA04003007A (es) | Compuestos azabiciclico sustituidos condensados con heteroarilo para el tratamiento de enfermedades. | |
| HUP0203526A2 (hu) | D4-antagonistákként alkalmazható tienoizoxazolil- és tienilpirazolil-fenoxi-helyettesített propilszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| GEP20125621B (en) | 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor | |
| HUP0303756A2 (hu) | 1-Aril- vagy 1-alkilszulfonil-heterociklobenzazolok és eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények | |
| MY136034A (en) | New medicaments for the treatment of chronic obstructive pulmonary disease | |
| SE0104340D0 (sv) | New compounds | |
| HUP0102851A2 (hu) | Parazitaellenes artemizinin-származékok (endoperoxidok), eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények | |
| EA200600811A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ | |
| SE0300480D0 (sv) | Novel compounds | |
| AU2002314914A1 (en) | Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases | |
| MX9707053A (es) | Nuevos derivados de arilglicinamida, procedimiento para su preparacion, y composiciones farmaceuticas que contienen estos compuestos. | |
| ATE401304T1 (de) | Kationisch substituierte diphenylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
| HUT75865A (en) | Tropane-2-aldoxime derivatives pharmaceutical compositions containing them, process for producing them and their use | |
| TW200626553A (en) | Novel compounds | |
| BG104983A (en) | Aryl fused azapolycyclic compounds | |
| HUP0202706A2 (hu) | D4 antagonistákként alkalmazható benzizoxazolil-, piridoizoxazolil- és benzitienil-fenoxi-származékok, intermedierjeik, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| EP3724163A1 (en) | Fluorinated 4-(substituted amino)phenyl carbamate derivatives | |
| RU2396264C2 (ru) | Производные хромана и их применение в качестве лигандов 5-нт рецептора | |
| HUP0402515A2 (hu) | Szubsztituált új N-[4-(1H-imidazol-1-il)-2-fluor-fenil]-3-(trifluor-metil)-1H-pirazol-5-karboxamidok Xa faktor inhibitorok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| DE60329607D1 (de) | Sich als therapeutische mittel eignende arylalkylindole mit affinität für den serotoninrezeptor, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten | |
| HUP0202712A2 (hu) | D4-antagonistákként alkalmazható tienoizoxazol fenoxi helyettesítetlen etil- és propilszármazékok, intermedierjeik és eljárás az előállításukra, és a vegyületeket tartalmazó gyógyszerkészítmények | |
| ATE417831T1 (de) | Ceramid ähnliche verbindungen, verfahren zu deren herstellung und deren verwendung als antitumormittel |